These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2968376)

  • 21. Edema and oral acyclovir.
    Medina S; Torrelo A; España A; Ledo A
    Int J Dermatol; 1991 Apr; 30(4):305-6. PubMed ID: 2050466
    [No Abstract]   [Full Text] [Related]  

  • 22. Acyclovir therapy for herpes zoster: advantages and adverse effects.
    Balfour HH
    JAMA; 1986 Jan; 255(3):387-8. PubMed ID: 3941520
    [No Abstract]   [Full Text] [Related]  

  • 23. Oral acyclovir for herpes zoster.
    Finn R; Smith MA
    Lancet; 1984 Sep; 2(8402):575. PubMed ID: 6147619
    [No Abstract]   [Full Text] [Related]  

  • 24. Open-label study of valacyclovir 1.5 g twice daily for the treatment of uncomplicated herpes zoster in immunocompetent patients 18 years of age or older.
    Madkan VK; Arora A; Babb-Tarbox M; Aboutlabeti S; Tyring S
    J Cutan Med Surg; 2007; 11(3):89-98. PubMed ID: 17511925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A topical solution of 40% idoxuridine in dimethyl sulfoxide compared to oral acyclovir in the treatment of herpes zoster. A double-blind multicenter clinical trial].
    Aliaga A; Armijo M; Camacho F; Castro A; Cruces M; Díaz JL; Fernández JM; Iglesias L; Ledo A; Mascaró JM
    Med Clin (Barc); 1992 Feb; 98(7):245-9. PubMed ID: 1560699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug treatment of herpes zoster.
    McGill J; James C; Hiscott P; Worstman T; Williams JH; Copplestone A; Larkin M
    Trans Ophthalmol Soc U K (1962); 1981; 101(1):3-5. PubMed ID: 6985235
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy of continuous, daily, oral, ultra-low-dose 200 mg acyclovir to prevent herpes zoster events among bortezomib-treated patients: a report from retrospective study.
    Aoki T; Nishiyama T; Imahashi N; Kitamura K
    Jpn J Clin Oncol; 2011 Jul; 41(7):876-81. PubMed ID: 21616919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral acyclovir in herpes zoster.
    McKendrick MW; Care C; Burke C; Hickmott E; McKendrick GD
    J Antimicrob Chemother; 1984 Dec; 14(6):661-5. PubMed ID: 6394572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurological deterioration in the treatment of Herpes zoster: encephalitis or neurotoxic effect of acyclovir?
    De Cauwer H; Maes J; Viaene M; Janssen L; Belmans L
    Acta Neurol Belg; 2017 Mar; 117(1):395-397. PubMed ID: 27418364
    [No Abstract]   [Full Text] [Related]  

  • 30. Oral and intravenous acyclovir are equally effective in herpes zoster.
    Peterslund NA; Esmann V; Ipsen J; Christensen KD; Petersen CM
    J Antimicrob Chemother; 1984 Aug; 14(2):185-9. PubMed ID: 6389470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acyclovir and herpes zoster.
    Thomas MG; Ellis-Pegler RB
    N Z Med J; 1989 Apr; 102(866):201. PubMed ID: 2710456
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of isoprinosine and acyclovir on the clinical course of chickenpox and herpes zoster].
    Janeczko J; Baranowska M; Romanowska B
    Przegl Epidemiol; 1991; 45(4):267-71. PubMed ID: 1726758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired renal function after bolus injections of acyclovir.
    Peterslund NA; Black FT; Tauris P
    Lancet; 1983 Jan; 1(8318):243-4. PubMed ID: 6130275
    [No Abstract]   [Full Text] [Related]  

  • 34. A randomized trial of oral versus intravenous acyclovir for treatment of herpes zoster in bone marrow transplant recipients. Nordic Bone Marrow Transplant Group.
    Ljungman P; Lönnqvist B; Ringdén O; Skinhöj P; Gahrton G
    Bone Marrow Transplant; 1989 Nov; 4(6):613-5. PubMed ID: 2684306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral acyclovir in acute herpes zoster.
    Marsh RJ; Cooper M
    Br Med J (Clin Res Ed); 1987 Mar; 294(6573):704. PubMed ID: 3105699
    [No Abstract]   [Full Text] [Related]  

  • 36. Neurotoxicity induced by the recommended acyclovir dosing in a dialysis patient with herpes zoster: A case letter.
    Kageyama R; Hashizume H
    J Dermatol; 2016 Mar; 43(3):339-40. PubMed ID: 26589129
    [No Abstract]   [Full Text] [Related]  

  • 37. Disseminated cutaneous herpes zoster complicated by acyclovir nephrotoxicity and successfully treated with brivudin.
    Aksoy B; Altaykan-Hapa A; Cengiz A; Mete Aksoy H; Atakan N
    Eur J Dermatol; 2010; 20(2):247-8. PubMed ID: 20103497
    [No Abstract]   [Full Text] [Related]  

  • 38. Prophylactic and suppressive treatment with acyclovir and the management of herpes in patients with acquired immunodeficiency syndrome.
    Conant MA
    J Am Acad Dermatol; 1988 Jan; 18(1 Pt 2):186-8. PubMed ID: 3339140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster.
    Wood MJ; Johnson RW; McKendrick MW; Taylor J; Mandal BK; Crooks J
    N Engl J Med; 1994 Mar; 330(13):896-900. PubMed ID: 8114860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral acyclovir for herpes zoster.
    McKendrick MW; McGill JI; Bell AM; Hickmott E; Burke C
    Lancet; 1984 Oct; 2(8408):925. PubMed ID: 6148641
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.